Skip to main content

4D Printing in Pharmaceuticals

  • Chapter
  • First Online:
Additive Manufacturing in Pharmaceuticals

Abstract

The term four-dimensional (4D) printing refers to the fabrication via additive manufacturing (AM) of structures with the capability to shape transform over time under a predefined stimulus (e.g., temperature, pH, electric field, humidity). Since its introduction in 2013, 4D printing has been in rapid expansion in several fields, including smart textiles, autonomous and soft robotics, biomedical devices, electronics, and tissue engineering. Shape-changing, self-repairing, and self-assembly are some of the characteristics usually associated with 4D printing, highlighting that 4D printed structures are no longer static objects but programmable active structures that accomplish their function through a change in their physical and/or chemical properties over time when exposed to a predetermined stimulus. Here, AM acts as an enabling technology by allowing a precise arrangement of an exact amount of one or more stimulus-responsive materials in predefined positions, without any constraints on the geometric complexity.

In the last few years, 4D printing has been exploited to develop increasingly sophisticated pharmaceutical and drug delivery systems, providing several advantages when compared with conventional fabrication approaches, such as (i) obtaining a highly controllable kinetic thanks to the smart properties and patterning of the involved stimulus-responsive material(s), (ii) achieving a time- and/or site-dependent drug release according to the shape-shifting of the structure after the sensing of a defined stimulus (e.g., change in pH or temperature, near-infrared lighting), and (iii) increasing the freedom to design systems able to settle, adapt, or remain and then release the conveyed drug in the target districts or move away from them.

In this chapter, we aim to provide the reader with an overview of 4D printing, as an emerging and breakthrough fabrication technology. Then, relevant examples from the recent literature regarding the use of 4D printing for the development of pharmaceutical and drug delivery systems are presented and deeply discussed.

Irene Chiesa and Amedeo Franco Bonatti are co-first authors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

Download references

Acknowledgements

This research received funding from the Italian Ministry of Education, University and Research (MUR) under the PRIN Project “Development and promotion of levulinic acid and carboxylate platforms by the formulation of novel and advanced PHA-based biomaterials and their exploitation for 3D-printed green-electronics applications” grant 2017FWC3WC. All authors acknowledge the support of the CrossLab Additive Manufacturing Department of Information Engineering of the University of Pisa.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carmelo De Maria .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Chiesa, I., Bonatti, A.F., De Acutis, A., Fortunato, G.M., Vozzi, G., De Maria, C. (2023). 4D Printing in Pharmaceuticals. In: Banerjee, S. (eds) Additive Manufacturing in Pharmaceuticals. Springer, Singapore. https://doi.org/10.1007/978-981-99-2404-2_8

Download citation

Publish with us

Policies and ethics